Deserpidine (Rauvolfia Indole Alkaloid · Antihypertensive · Informational)
Compiled from published pharmacological and botanical literature. Not independently verified by Herbuno. Spotted an error or have a correction? Flag it below →
| Compound | Deserpidine (Canescine; Recanescine) |
| Chemical class | Alkaloid — Indole (yohimbane-type; Rauvolfia alkaloid; 11-demethoxyreserpine) |
| CAS | 131-01-1 |
| Primary source | Rauvolfia canescens / Rauvolfia serpentina, roots |
| Key applications | Historic antihypertensive and tranquilliser; reserpine analogue; informational-only |
| Claim strength | High (pharmaceutical, historic) |
| Typical form | Pharmaceutical (historic); not a supplement ingredient |
| Buy from Herbuno | Informational reference — see HerbIQ Compound Index → |
Name origin: Deserpidine, also known as canescine or recanescine, is the 11-demethoxy analogue of reserpine — the des- prefix marking the methoxy group that reserpine has and deserpidine lacks. It is a yohimbane-type Rauwolfia indole alkaloid and, with reserpine and rescinnamine, one of the three principal alkaloids of the genus. Traditional use: As a Rauwolfia constituent, deserpidine belongs to the alkaloid complex behind the genus’s long use in Indian medicine for hypertension, agitation, and mental disturbance; it was first prominently obtained from Rauvolfia canescens. It has no separate traditional identity from the whole-root preparation. Research trajectory: Deserpidine occurs at limited levels in natural sources, so a practical semisynthesis from the more abundant reserpine was developed — a six-step conversion reported in good overall yield synthesis 2005. Therapeutically it was used as an antihypertensive and tranquilliser within the same Rauwolfia pharmacology described in clinical reviews of the genus, which document how reserpine and its congeners lower blood pressure through peripheral monoamine depletion and act centrally as tranquillisers Lobay 2015. Commercial source: Deserpidine is a historic pharmaceutical alkaloid, included in HerbIQ as a chemical-family reference.
Evidence for Deserpidine Applications
Antihypertensive and tranquilliser use: Deserpidine shares reserpine’s Rauwolfia pharmacology and was used to lower blood pressure and relieve agitation within the mid-twentieth-century Rauwolfia therapeutic tradition, in which the alkaloids act peripherally to deplete sympathetic noradrenaline and centrally as tranquillisers Lobay 2015. Claim strength: High (pharmaceutical, historic).
Semisynthesis from reserpine: Because natural deserpidine is limited in availability, a six-step semisynthesis from the more plentiful reserpine (reported at about 41% overall yield) provides practical access to the compound, illustrating how the closely related Rauwolfia alkaloids can be interconverted chemically synthesis 2005. Claim strength: High.
Reserpine relationship: As the 11-demethoxy analogue of reserpine, deserpidine shares the vesicular-monoamine-depleting mechanism of the class and, with it, the same liability to depression and sedation from central monoamine depletion. Claim strength: Moderate.
Historic significance: Deserpidine is one of the three principal Rauwolfia indole alkaloids, with reserpine and rescinnamine, that together defined botanical antihypertensive therapy of its era and shaped the early standardised Rauwolfia extracts Lobay 2015. Claim strength: Moderate.
Distribution in the plant: Like the other Rauwolfia alkaloids, deserpidine is concentrated in root material and varies in content with source, which is why standardised extracts and analytical assay were necessary historically to deliver a reproducible dose. Claim strength: Moderate.
Comparative tolerability: Within the Rauwolfia group, deserpidine was regarded as broadly similar to reserpine in effect and in its liability to central side effects such as depression and sedation, and it offered no decisive advantage that would preserve its use once better-tolerated synthetic antihypertensives became available. Its history therefore closely parallels that of reserpine and rescinnamine. Claim strength: Moderate.
This compound is documented for research and formulator education purposes. For commercially available botanical ingredients, explore the HerbIQ Compound Index →
Dosage & Formulator Specification
Deserpidine is a historic pharmaceutical alkaloid with no dietary-supplement application and no consumer dosing. Rauwolfia antihypertensives were dosed in fraction-of-a-milligram amounts under medical supervision, reflecting the potency and narrow therapeutic window of the class.
Rauvolfia species are regulated botanicals, and isolated Rauwolfia alkaloids carry defined cardiovascular and CNS risks, including depression from central monoamine depletion. There is no supplement-grade deserpidine application, and formulators should treat any Rauvolfia material as a controlled multi-alkaloid feedstock rather than an ingredient.
Where Rauvolfia material is evaluated at all, the co-occurrence of deserpidine with reserpine, rescinnamine, and ajmaline means total-alkaloid and individual-alkaloid profiling by HPLC is the only defensible specification, since the pharmacological character of the material depends on the full alkaloid distribution rather than any single marker. The interconvertibility of these alkaloids — deserpidine can be made from reserpine — underlines how closely related and how collectively potent they are.
A further practical point concerns the source species. Deserpidine was obtained prominently from Rauvolfia canescens rather than Rauvolfia serpentina, and different Rauvolfia species carry different proportions of the individual alkaloids, so the botanical origin of any Rauvolfia material materially affects its deserpidine content. This species-dependence is one more reason that assay, rather than assumed composition, must govern any handling of Rauvolfia-derived material, and it parallels the species distinctions that matter elsewhere in the botanical-alkaloid literature.
Deserpidine’s interconvertibility with reserpine is more than a laboratory curiosity: it means the two alkaloids are effectively members of a single closely related chemical set whose members can be produced from one another, and it explains why the pharmacology, cautions, and regulatory treatment of deserpidine track those of reserpine so closely. For anyone characterising Rauvolfia material, this reinforces that the meaningful unit is the whole alkaloid profile, since the individual esters differ only in small structural details and share a common mechanism.
This page documents deserpidine as a chemical-family reference within the HerbIQ index, connecting it to reserpine, rescinnamine, ajmaline, and the other Rauvolfia alkaloids covered elsewhere, and is explicitly not a sourcing recommendation.
Frequently Asked Questions — Deserpidine
What is deserpidine?
Deserpidine is a yohimbane-type indole alkaloid of Rauvolfia (notably Rauvolfia canescens), closely related to reserpine, that was used historically as an antihypertensive and tranquilliser. It is the 11-demethoxy analogue of reserpine.
How does deserpidine relate to reserpine?
Deserpidine is the 11-demethoxy analogue of reserpine, lacking one methoxy group, and it shares the Rauwolfia origin and the vesicular-monoamine-depleting action of the parent compound. Because natural deserpidine is limited, it can be prepared semisynthetically from the more abundant reserpine.
Why is deserpidine informational-only?
It is a prescription-era Rauwolfia alkaloid, not a dietary-supplement ingredient, and appears in HerbIQ as a chemical-family reference rather than as a sourceable ingredient.
What was deserpidine used for?
Deserpidine was used to control high blood pressure and to relieve agitation and psychotic behaviour, within the same therapeutic tradition as reserpine, before modern agents superseded it. Its effects and risks mirror those of reserpine, including the potential for depression from central monoamine depletion.
Related compounds: Reserpine, Rescinnamine, Ajmaline, Serpentine
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery